Manama, October 7 (BNA) The Speaker of the Shura Council, Ali bin Saleh Al-Saleh, praised the directives of His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, to provide a life-changing revolutionary crizanlizumab. Pharmacological treatment of patients with sickle cell disease after completion of clinical trials.
He stressed that the directives of His Highness the Crown Prince and the Prime Minister reflect the Kingdom’s interest in ensuring the health and safety of its citizens by providing the latest medical and treatment technologies.
Al-Saleh said that providing the drug within the treatment protocol in the Kingdom after the National Health Service in the United Kingdom confirmed its effectiveness would send a glimmer of hope for sickle cell patients, especially since it was the first that became available. disease in 20 years.
He pointed out that the rapid and advanced step keeps pace with the Kingdom’s achievements in combating the spread of diseases and epidemics, which was evident in the Kingdom’s success in the second place globally and first in the Arab world in the Nikkei Index for recovery from Covid-19 disease. .
Al-Saleh affirmed the Shura Council’s support for the steps and measures taken by the government, led by His Highness the Crown Prince and Prime Minister, to improve the quality of services provided to citizens in various fields.
NS